{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T02:22:11Z","timestamp":1790043731789,"version":"4.0.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brain and Development"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1016\/j.braindev.2010.02.005","type":"journal-article","created":{"date-parts":[[2010,3,22]],"date-time":"2010-03-22T08:21:09Z","timestamp":1269246069000},"page":"131-139","source":"Crossref","is-referenced-by-count":47,"title":["A French experience of type 3 Gaucher disease: Phenotypic diversity and neurological outcome of 10 patients"],"prefix":"10.1016","volume":"33","author":[{"given":"Ichraf","family":"Kraoua","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Sedel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Caillaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roseline","family":"Froissart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Stirnemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Chaurand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugues","family":"Flodrops","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saliha","family":"Tari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Gourfinkel-An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Mathieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Belmatoug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Billette de Villemeur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyril","family":"Mignot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.braindev.2010.02.005_b0005","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/S0140-6736(08)61522-6","article-title":"Phenotype, diagnosis, and treatment of Gaucher\u2019s disease","volume":"372","author":"Grabowski","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.braindev.2010.02.005_b0010","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/ajmg.a.20117","article-title":"Perinatal-lethal Gaucher disease","volume":"120A","author":"Mignot","year":"2003","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.braindev.2010.02.005_b0015","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0065-3101(24)00037-9","article-title":"Hydrops fetalis: lysosomal storage disorders in extremis","volume":"46","author":"Stone","year":"1999","journal-title":"Adv Pediatr"},{"key":"10.1016\/j.braindev.2010.02.005_b0020","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.braindev.2005.04.005","article-title":"Type 2 Gaucher disease: 15 new cases and review of the literature","volume":"28","author":"Mignot","year":"2006","journal-title":"Brain Dev"},{"key":"10.1016\/j.braindev.2010.02.005_b0025","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0065-3101(24)00049-5","article-title":"New perspectives in type 2 Gaucher disease","volume":"44","author":"Sidransky","year":"1997","journal-title":"Adv Pediatr"},{"key":"10.1016\/j.braindev.2010.02.005_b0030","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1212\/WNL.43.10.1993","article-title":"Isolated horizontal supranuclear gaze palsy as a marker of severe systemic involvement in Gaucher\u2019s disease","volume":"43","author":"Patterson","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.braindev.2010.02.005_b0035","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1212\/WNL.54.1.261","article-title":"Gaucher disease with oculomotor apraxia and cardiovascular calcification (Gaucher type IIIC)","volume":"54","author":"Bohlega","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.braindev.2010.02.005_b0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1651-2227.1986.tb14936.x","article-title":"Gaucher disease\u2013Norrbottnian type (III). Neuropaediatric and neurobiological aspects of clinical patterns and treatment","volume":"326","author":"Erikson","year":"1986","journal-title":"Acta Paediatr Scand Suppl"},{"key":"10.1016\/j.braindev.2010.02.005_b0045","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s10545-007-0577-z","article-title":"Outcome of type III Gaucher disease on enzyme replacement therapy: review of 55 cases","volume":"30","author":"Davies","year":"2007","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.braindev.2010.02.005_b0050","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1067\/mpd.2001.112171","article-title":"The efficacy of enzyme replacement therapy in patients with chronic neuronopathic Gaucher\u2019s disease","volume":"138","author":"Altarescu","year":"2001","journal-title":"J Pediatr"},{"key":"10.1016\/j.braindev.2010.02.005_b0055","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1080\/08035250500423804","article-title":"Ten years\u2019 experience of enzyme infusion therapy of Norrbottnian (type 3) Gaucher disease","volume":"95","author":"Erikson","year":"2006","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.braindev.2010.02.005_b0060","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/ana.410420412","article-title":"Prospective study of neurological responses to treatment with macrophage-targeted glucocerebrosidase in patients with type 3 Gaucher\u2019s disease","volume":"42","author":"Schiffmann","year":"1997","journal-title":"Ann Neurol"},{"key":"10.1016\/j.braindev.2010.02.005_b0065","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1023\/A:1005495229655","article-title":"Enzyme replacement therapy in type III Gaucher disease","volume":"22","author":"Tylki-Szymanska","year":"1999","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.braindev.2010.02.005_b0070","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ymgme.2009.05.001","article-title":"Clinical and genetic study of Japanese patients with type 3 Gaucher disease","volume":"97","author":"Tajima","year":"2009","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.braindev.2010.02.005_b0075","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1136\/jnnp.70.1.133","article-title":"Atypical course of neuropathic Gaucher\u2019s disease: follow up from early infancy until adulthood","volume":"70","author":"Baumann","year":"2001","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.braindev.2010.02.005_b0080","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1067\/S0022-3476(03)00302-0","article-title":"Phenotypic continuum in neuronopathic Gaucher disease: an intermediate phenotype between type 2 and type 3","volume":"143","author":"Goker-Alpan","year":"2003","journal-title":"J Pediatr"},{"key":"10.1016\/j.braindev.2010.02.005_b0085","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/ana.21491","article-title":"Randomized, controlled trial of miglustat in Gaucher\u2019s disease type 3","volume":"64","author":"Schiffmann","year":"2008","journal-title":"Ann Neurol"},{"key":"10.1016\/j.braindev.2010.02.005_b0090","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s10545-008-0873-2","article-title":"Potential efficacy of enzyme replacement and substrate reduction therapy in three siblings with Gaucher disease type III","volume":"31","author":"Cox-Brinkman","year":"2008","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.braindev.2010.02.005_b0095","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1111\/j.1528-1167.2007.01074.x","article-title":"Neurologic improvement in a type 3 Gaucher disease patient treated with imiglucerase\/miglustat combination","volume":"48","author":"Capablo","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.braindev.2010.02.005_b0100","unstructured":"Tylki-Szymanska A, Vellodi A, El-Beshlawy A, Cole LA, Kolodny E. Clinical and demographic characteristics of 122 patients with type 3 Gaucher disease. Gaucher Registry Annual Report, 2008."},{"key":"10.1016\/j.braindev.2010.02.005_b0105","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S0387-7604(12)80029-5","article-title":"Uncoupling of blood flow and oxygen metabolism in the cerebellum in type 3 Gaucher disease","volume":"13","author":"Yoshikawa","year":"1991","journal-title":"Brain Dev"},{"key":"10.1016\/j.braindev.2010.02.005_b0110","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1136\/jnnp.38.9.849","article-title":"Progressive myoclonic epilepsy due to Gaucher\u2019s disease in an adult","volume":"38","author":"King","year":"1975","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.braindev.2010.02.005_b0115","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1111\/j.0013-9580.2004.15904.x","article-title":"Early visual seizures and progressive myoclonus epilepsy in neuronopathic Gaucher disease due to a rare compound heterozygosity (N188S\/S107L)","volume":"45","author":"Filocamo","year":"2004","journal-title":"Epilepsia"},{"key":"10.1016\/j.braindev.2010.02.005_b0120","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1203\/00006450-198305000-00007","article-title":"Biochemical studies in a patient with subacute neuropathic Gaucher disease without visceral glucosylceramide storage","volume":"17","author":"Wenger","year":"1983","journal-title":"Pediatr Res"},{"key":"10.1016\/j.braindev.2010.02.005_b0125","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1203\/01.PDR.0000049515.79882.94","article-title":"Myoclonic epilepsy in Gaucher disease: genotype-phenotype insights from a rare patient subgroup","volume":"53","author":"Park","year":"2003","journal-title":"Pediatr Res"},{"key":"10.1016\/j.braindev.2010.02.005_b0130","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.bcmd.2008.11.002","article-title":"Promising results of the chaperone effect caused by iminosugars and aminocyclitol derivatives on mutant glucocerebrosidases causing Gaucher disease","volume":"42","author":"Sanchez-Olle","year":"2009","journal-title":"Blood Cells Mol Dis"},{"issue":"Suppl. 1","key":"10.1016\/j.braindev.2010.02.005_b0135","first-page":"21","article-title":"Gaucher patients homozygous for the L444P mutation: pitfalls of treatment","volume":"29","author":"Eyskens","year":"2006","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.braindev.2010.02.005_b0140","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s004310000630","article-title":"Improvement of neurological symptoms by enzyme replacement therapy for Gaucher disease type IIIb","volume":"160","author":"Aoki","year":"2001","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.braindev.2010.02.005_b0145","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s10545-007-0783-8","article-title":"No justification for very high-dose enzyme therapy for patients with type III Gaucher disease","volume":"30","author":"Zimran","year":"2007","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.braindev.2010.02.005_b0150","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/S0022-3476(82)80650-1","article-title":"Acute neuronopathic (infantile) and chronic nonneuronopathic (adult) Gaucher disease in full siblings","volume":"100","author":"Wenger","year":"1982","journal-title":"J Pediatr"},{"key":"10.1016\/j.braindev.2010.02.005_b0155","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1086\/302925","article-title":"Analysis and classification of 304 mutant alleles in patients with type 1 and type 3 Gaucher disease","volume":"66","author":"Koprivica","year":"2000","journal-title":"Am J Hum Genet"}],"container-title":["Brain and Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760410000604?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760410000604?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T07:38:17Z","timestamp":1711352297000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0387760410000604"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["S0387760410000604"],"URL":"https:\/\/doi.org\/10.1016\/j.braindev.2010.02.005","relation":{},"ISSN":["0387-7604"],"issn-type":[{"value":"0387-7604","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]}}}